English | Español
English | Español
  • Insurance
  • Marketing
  • Pharmaceuticals
  • Technology/Innovation
  • Regulatory
  • Community

Pharmaceuticals

+ Pharmaceuticals
Patient Daily | Jul 11, 2026

Researchers explore immune-engineered stem cell therapy for type 1 diabetes at ISSCR meeting

+ Pharmaceuticals
Patient Daily | Jul 11, 2026

Researchers develop machine learning model for accurate water toxin detection

+ Pharmaceuticals
Patient Daily | Jul 11, 2026

Study links oxalate to inflammation and heart damage in kidney disease patients

+ Pharmaceuticals
Patient Daily | Jul 11, 2026

Study finds integrative oncology program improves cancer-related symptoms and patient satisfaction

+ Pharmaceuticals
Patient Daily | Jul 11, 2026

Researchers develop bionic skin wound dressing for improved healing and infection control

+ Pharmaceuticals
Patient Daily | Jul 11, 2026

Penn State receives grant to launch street medicine program for homeless populations

+ Pharmaceuticals
Patient Daily | Jul 11, 2026

Study reveals how glioma brain tumors evolve to resist treatment

+ Pharmaceuticals
Patient Daily | Jul 11, 2026

Cruise ship pollution linked to increased viral infection risk in port cities

Trending

+ Pharmaceuticals
Patient Daily | Aug 6, 2026

FDA approves Replimune’s melanoma drug Tudriqev after advisory committee debate

+ Pharmaceuticals
Patient Daily | Aug 4, 2026

Merck reports mixed results for tulisokibart in recent clinical trials and financial update

+ Regulatory
M. Y. Bailey | Aug 7, 2026

PhRMA's Zirkelbach: 340B program has changed dramatically with 'little transparency into how patients benefit'

Patient Daily reports | Aug 10, 2026

SoCal Breathe Free warns persistent sinus symptoms may signal chronic inflammation

  • « First
  • «
  • …
  • 32
  • 33
  • 34
  • 35
  • 36
  • 37
  • 38
  • …
  • »
  • Last »


Community
Insurance
Marketing
Pharmaceuticals
Regulatory
Technology/Innovation
About
Contact
© 2026 Patient Daily